Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Fanconi Anemia × SRA737 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Classical hematology 1

Conditions

Small Cell Lung Carcinoma 1 Sarcoma 1 Fanconi Anemia 1

Interventions

fludarabine phosphate 1 SRA737 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Gemcitabine 1 Cord Blood Stem Cell Transplantation 1 Cisplatin 1 Busulfan 1 Antilymphocyte Serum 1 Afatinib 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed

Classical hematologySarcomaThoracic

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡